NOTV - Inotiv, Inc.
1.91
0.040 2.094%
Share volume: 262,054
Last Updated: 04-28-2025
Business Services/Services – Research, Development, Testing Labs:
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$1.87
0.04
0.02%
Fundamental analysis
21%
Profitability
0%
Dept financing
24%
Liquidity
29%
Performance
40%
Performance
5 Days
-0.52%
1 Month
-13.57%
3 Months
-56.49%
6 Months
4.95%
1 Year
-48.93%
2 Year
-66.31%
Key data
Stock price
$1.91
DAY RANGE
$1.81 - $1.93
52 WEEK RANGE
$1.15 - $6.48
52 WEEK CHANGE
-$50.26
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-09-2025
Company detail

CEO: Robert Leasure
Region: US
Website: inotivco.com
Employees: 2,100
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
Region: US
Website: inotivco.com
Employees: 2,100
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
Inotiv, Inc. provides drug discovery and development services to pharmaceutical, chemical, and medical device industries. It operates through two segments, Contract Research Services and Research Products. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally.
Recent news
